Expression of Nucleostemin gene in tumor cells derived from human embryomic bone marrow mesenchymal stem cells
10.3760/cma.j.issn.1006-9801.2009.10.001
- VernacularTitle:Nucleostemin基因在骨髓间充质干细胞诱导致瘤过程中的表达
- Author:
Chongxu HAN
;
Wenrong XU
;
Yan SUN
;
Xiran ZHANG
- Publication Type:Journal Article
- Keywords:
Bone marrow;
Mesenchymal stem cells;
Tumor cells;
cultured;
Cells,Nucleostemin
- From:
Cancer Research and Clinic
2009;21(10):649-653
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the tumorigenesis mechanism in bone marrow mesenchyme stem cells (MSC). Methods The bone marrow MSC could be induced into turnout (F6 cells) in vitro. The difference between gene expression of F6 cells and MSC was distinguished by fluorescent differential display (FDD). Verification of the result was detected by Real time RT-PCR and Western blotting, and immunocytochemistry. Results FDD analysis confirmed that Nucleostemin (NS) was positively up-regulated in F6 cells compared with MSC. Similar results were obtained by PCR and Western blotting. The NS gene expression levels in MSC, F6, 176-4, F6-6 and F6-7 were significantly different(F =160, P <0.05). The NS gene expression level in F6 (0.0372±0.0019) was 18 folds higher than those of MSC(0.0021±0.0002,P <0.05). Expression levels in F6-4, F6-6 and F6-7 tissue were 0.0504±0.0083, 0.0995±0.0026 and 0.0614±0.0036, and were significantly higher than that in MSC(P <0.05). The expression of NS increased significantly with the accreting volume of turnour, and high-level protein expression of NS was confirmed by Western blotting and immunocytochemistry. Conclusion The expression level of NS might be one of the factors playing important roles during turnour genesis, especially in MSC mutation.
